Intelligent Asthma Monitoring Devices Market

Intelligent Asthma Monitoring Devices Market Statistics - 2030

The global intelligent asthma monitoring devices market size was valued at $180.5 Million in 2020, and is projected to reach $1,696.7 Million by 2030, registering a CAGR of 25.1% from 2021 to 2030. Asthma monitoring device monitors the symptoms of asthma on a daily basis to prevent asthma attack and its associated complications. Intelligent asthma monitoring device is equipped with secondary app, which helps medical practitioner in analyzing the level of asthma and its symptoms.

COVID Statement: The COVID-19 outbreak is anticipated to have a positive impact on intelligent asthma monitoring devices Market. Rise in prevalence rate of chronic respiratory diseases is expected to further drive the growth of the respiratory monitoring devices market in the near future.

The prevalence of asthma is increasing at an alarming rate due to rise in allergic reactions toward the pollen, dust, and other allergens; increase in geriatric population; and advancements in the intelligent asthma monitoring devices market. As per of the World Health Organization in 2019, 262 million of people suffered from asthma worldwide. It is the most common chronic condition prevalent among children. According to WHO, approximately 1.31 million individuals have undergone asthma treatment globally in 2019.

Asthma management requires patient’s active commitment to engage in self-monitoring routines. Asthma self-monitoring includes symptom-based and peak expiratory flow (PEF) monitoring. Technological advancements in the healthcare system have led to the development of digital devices that alert patients of a possible asthma attack. These monitoring devices have the ability to monitor adherence, provide access to data so that it can be transported to a personal device, and accurately record the time of each dose taken by the patient. Mobile health and web applications (apps), wearables, and other personal monitoring devices have tremendous potential to improve the management of asthma.

Global Intelligent Asthma Monitoring Devices Market Segmentation

The global intelligent asthma monitoring devices market is segmented into product, end user, and region. Depending on product, the market is bifurcated into wearable asthma monitoring devices and smart inhalers. The smart inhalers segment is further bifurcated into inhalers and nebulizers. The inhalers segment is subsegmented into dry powdered inhalers and metered dose inhalers. On the basis of end user, the market is fragmented into hospital, clinics, and home use.

Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Segment Review

By product, the smart inhalers segment dominated the market, and is expected to grow at the fastest rate owing, to increase in acceptance of smart inhalers and patient compliance. 

On the basis of end user, the hospital segment led the global intelligent asthma monitoring devices market, and is anticipated to grow at a significant pace during the forecast period. On the contrary, the home use segment is expected to exhibit the fastest growth rate during the forecast period, due to increase in the number of phone-based apps and smart inhalers that can be handled with ease.

North America accounted for the largest market share in 2020, and is expected to retain its dominance throughout the forecast period. This is attributed to exponential increase in population coupled with rise in geriatric population. In addition, surge in healthcare expenditure and development in guidelines for diagnosis and management of asthma are expected to propel the intelligent asthma monitoring devices market growth.

The major companies profiled in this report include Adherium, Astrazeneca, Cohero Health Inc, Glaxosmithkline PLC, Health Care Originals, Koninklijke Philips N.V, Propeller Health, Teva Pharmaceuticals Industries Ltd., Vectura group Plc., and Volansys Technologies.

Key Benefits for Stakeholders

• This report provides an extensive analysis of the current and emerging market trends in the global intelligent asthma monitoring devices market to identify the prevailing opportunities.
• This study presents the competitive landscape of the global intelligent asthma monitoring devices market to predict the competitive environment across geographies.
• Comprehensive analysis of factors that drive and restrict the intelligent asthma monitoring devices market growth is provided.
• Region- & country-wise analysis is provided to understand the intelligent asthma monitoring devices market trends and dynamics.

 Intelligent Asthma Monitoring Devices Market Report Highlights